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ABSTRACT 
 Background: Non-steroid anti-inflammatory drugs (NSAIDs) are the most widely used 
analgesics and are available without prescription. NSAIDs can be acquired outside of 
pharmacies, the increase in NSAID consumption and the decrease in professional counseling 
(by physicians and pharmacists) may pose a serious risk for a substantial increase in adverse 
effect occurrences. Literature documents several factors affecting the possibility of analgesic 
misuse such as health status, the frequency and the manner of using analgesics, education and 
literacy skills (knowledge of safe usage, dosing, combining with other drugs etc.).Aim: The 
aim of this study was to recognize and describe the important predictive factors of the 
misuse of prescription analgesics among urban young adults of either sex in Sikkim, India. 
Methods: A pre devised validated case record form was administered to n=700 subjects. Data 
was statistically analyzed using Statistical Package of Social Sciences software. Results: 
Statistically significant results were obtained for pain in the past 30 days (χ2  = 23.282, df=1, 
P<0.001), source of income (χ2 = 7.326, df=2, P=0.026), smoking in the past 30 days (χ2 = 
14.430, df=2, P=0.001), body mass index (χ2 = 140.224, df=2, P<0.001) and depression (χ2  = 
13.811, df=2, P=0.001).Conclusion: Several socio-demographic and lifestyle factors along 
with smoking in the past one month were associated with a continuous regular analgesic 
misuse of method was carried out utilizing ICH-guidelines. The described HPLC method 
method was successfully for the analysis of pharmaceutical formulations containing dosage 
form. 
Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are one of 
the most commonly used medications worldwide without 
prescription and as Over the Counter (OTC). The huge 
availability of products containing an NSAID, combined with 
a lack of recognition and understanding of NSAIDs, can 
increase the potential of consumers to exceed the 
recommended NSAID dosage, which can cause serious side 
effects. Appropriate physician and consumer education 
regarding the use of NSAIDs can help prevent misuse of 
NSAIDs. Recent patterns of NSAID use and perceptions 
about NSAIDs are necessary to develop targeted educational 
programs. The aim of this study was to recognize and describe 
the important predictive factors of the misuse of prescription 
analgesics among urban young adults of Sikkim, India. 
NSAIDs are not well recognized by generic or brand names 
and many respondents are unaware or unconcerned about its 
potential side effects. NSAIDs are widely used and often used 
in a manner that increases the risk of serious side effects. 
[1]The literature refers that in countries where prescription 
NSAIDs can be acquired outside of pharmacies, the increase 
in NSAID consumption and the decrease in professional 
counselling (by physicians and pharmacists) may pose a 
serious risk for a substantial increase in adverse effect 
occurrences. [2]
 
NSAID use patterns have been documented 
for various populations. In Italy, NSAID usage is common and 
more prevalent in the elderly and in females. [3] NSAID 
adverse effects have been extensively surveyed, particularly in 
the last decade, and in high risk patients, including the elderly. 
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[4] There are numerous factors inherent to the elderly, such as 
co-morbidities and polypharmacy, make the aged highly 
susceptible to develop drug related problems. [5] The authors 
understand the misuse of analgesics as a situation in which 
patients use medicines in a manner contrary to their purpose 
and when they incorrectly combine medicines with other 
drugs and substances, overdose or consume them contrary to 
professional recommendations. Factors affecting the 
possibility of analgesic misuse are health status, the frequency 
and the manner of using analgesics, education and literacy 
skills (knowledge of safe usage, dosing, combining with other 
drugs etc.). Analgesic misuse was defined in this study as any 
current (past 30 days) use of analgesics (greater than or equal 
to 10 doses/month) for indications other than everyday kind of 
pain (e.g., minor headache, sprain, toothache, pre-menstrual 
syndrome) without medical advice. [6-9] 
Materials and Methods 
Selection of study subjects: In this study only young adults 
(15 – 40 years of age) of either sex were enrolled as 
participants as this population were less likely to have co-
morbid age-related chronic medical conditions requiring 
regular analgesic use; more likely to develop adverse 
consequences of regular analgesic use like gastrointestinal and 
renal adverse events as well as dependence over their lifetime; 
and this population was the best group for preventive 
measures.   
Sampling Method & Size: Current population of Gangtok is 
approximately 98,658, [10] i.e., approximately 1,00,000. 
According to current population pyramid of India 
approximately 35% of the total population belongs to the age 
group of 15 – 40 years. [11] Therefore, in Gangtok, an 
approximate 35,000 people are expected to be in the age group 
of 15 – 40. Prevalence of regular analgesic use in age groups 
above 14 years has been reported in the range of 7.2 to 34.8% 
in European studies. Therefore, considering a younger age 
group of our study population (15 – 40 years) we assume an 
estimated prevalence of 5% analgesic misuse with an 
acceptable lower limit of 2% in both rural and urban sites. To 
detect this prevalence at a 95% confidence interval the study 
enrolled n=700 subjects at the urban Gangtok site. Further 
stratification according to age groups and gender was carried 
out during recruitment and stratification was adjusted 
according to actual percentage of population according to 
gender and age groups (15 – 20 years, 21 – 30 years and 31 – 
40 years).The sampling strategy involved identification of 
sampling locations in each site. Sampling locations mostly 
included schools (age group 15 – 17 years), colleges (age 
group 18 – 22 years) and households where people in the age 
group of 15 – 40 years commonly aggregate and live. The 
study did not involve only a household survey, but assumed a 
more ethnographic approach. Any subject satisfying the age 
criteria for inclusion was eligible for the study. To minimize 
the uncertainty of data and to make the sample reliable, the 
authors have tried to maximize its resemblance to the 
population’s characteristic by selecting participants by 
specified attributes: sex, age and level of education. In our 
study, the median age of participants was 28 years. Referring 
to the most important socio-demographic factors (sex and 
median age), the authors’ sample is representative or 
approximate to the representative group.  
Instruments: The source document was a validated case 
record form constituting the following: 
 A generic socio-demographics section (e.g., age, gender, 
education, ethnicity etc.), which is a 21-item 
questionnaire including questions on alcohol use and 
smoking.  
 A generic analgesic misuse questionnaire, comprising 
measures of non-steroidal and opioid analgesic use 
without medical advice, which is a 21-item questionnaire 
including information on treatment of pain and ease of 
availability of analgesics.  
 Brief Pain Inventory is a standardized instrument for 
assessment of pain. Brief Pain Inventory (BPI) is a 9-item 
instrument assessing pain in different domains of 
functionality from a participant’s perspective. It has been 
reported that BPI satisfies most key recommendations 
outlined in the draft guidance for assessing a pain-
reduction treatment effect. The draft guideline was 
recommended in 2006 by the United States Food and 
Drug Administration (FDA) on the use of patient-reported 
outcomes (PRO) Measures in Medical Product 
Development to Support Labeling Claims. This draft 
guidance outlines psychometric aspects that should be 
considered when designing a PRO measure, including 
conceptual framework, content validity, construct 
validity, reliability, and the ability to detect clinically 
meaningful score changes. [12] 
 SF – 36, quality of life questionnaire, which is an 11-item 
standardized instrument for assessment of quality of life 
in different domains. Considerable evidence was found 
for the reliability of the SF-36 (Cronbach's alpha greater 
than 0.85, reliability coefficient greater than 0.75 for all 
dimensions except social functioning) and for construct 
validity in terms of distinguishing between groups with 
expected health differences. The SF-36 was able to detect 
low levels of ill health. The SF-36 was reported as a 
promising new instrument for measuring health 
perception in a general population. It is easy to use, 
acceptable to patients and fulfils stringent criteria of 
reliability and validity.
 
[13] 
Ethical Issues: The study consisted of only interviews and 
subsequent data analysis from questionnaires and did not 
involve any patient contact, medical, behavioral, therapeutic 
or instrumental intervention. The study protocol, 
instruments/questionnaire, informed consent was duly 
approved by Institutional Ethics Committee (IEC). 
Design and Study Sites: The study was a cross-sectional 
general population survey. Proposed study site included an 
urban area in East Sikkim. The selected urban site was 
Gangtok and its surroundings, East Sikkim, the most 
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important city in Sikkim. Identification as urban site was 
based on criteria provided by Urban Development and 
Housing Department, Government of Sikkim, Gangtok.  
The study was conducted during the period of April, 2013 to 
October, 2015. A total of n=700 subjects were screened during 
this period. They were the target population of the study.  
Data Collection: Data collection was based on personal 
interviews with the participants. Before interview, the 
participants were explained about the nature and objective of 
the study and the nature of questions involved. Confidentiality 
was ensured and it was also mentioned that they have the 
freedom of refraining from any response. The respondents 
were also briefed about the need of their honest answers in 
order to get correct information. Informed consent was 
obtained from competent person. The informed consent form 
was originally made in English language and then was 
translated to Hindi and Nepali language for a better 
understanding of the participants. They were given a copy of 
the signed informed consent. Participants were not given any 
monetary or other compensation in lieu of participation in the 
study. 
Statistical Analysis: Data was fed in Statistical Package for 
the Social Sciences (SPSS), version 20, IBM Corp. Before 
analysis all entries were checked and cleaned by ignoring or 
putting missing value codes for inconsistent or ambiguous 
values. Chi-square was run for nonparametric data to show the 
significant difference, if any. A significance level less than 
0.05 (p < 0.005) was considered as statistically significant. 
The obtained results were presented in tables and charts.   
Table 1: Analgesic Use greater than equal to 10 doses per month in the past 30 days 
Category                                                                           Frequency (N)    Percentage (%) 
    
Without prescription- 
Other than everyday  
kind of pain 
                  91      72.80 
With prescription and Without 
prescription-Regular pain 
               
               
 
               
             
         
   34 
   
 
     27.20 
Total    125     100 
 
Table 2: Lifetime analgesic use and use of more than one analgesic in the past 30 days 
Category                                                                           Frequency (N) Percentage (%) 
    
 
Lifetime analgesic used in the past 30 days 
Yes 
No 
                   
   
  313 
  387 
      
      
     44.70 
     55.30 
 
More than one analgesic used in the past 30 days 
Yes 
No 
               
               
 
               
             
         
   
 33 
   58        
    
 
      
36.30 
     63.70      
 
Table 3: Analgesics frequently misused in the past 30 days 
Drugs                                                                         Frequency (N) Percentage(%) 
    
Paracetamol                   49   53.80 
Ibuprofen 
Aspirin 
Diclofenac 
               
               
 
               
             
   28  
   08 
   06     
    
30.80 
   8.80 
6.60 
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Table 4: Predictors of Analgesic misuse 
Category Analgesic Misuse 
(%) 
No  
Misuse (%) 
P 
    
 
Pain in the past 30 days 
Yes 
No 
 
 
Source of Income 
Salaried 
Self-employed 
Unemployed 
 
 
Age 
15-25 years                                                                       
26-35 years 
36-40 years 
 
 
Smoking in the past 30 days 
None 
Less than 10 times 
10 times and more 
 
 
Alcohol use in the past 30 days 
No use 
Less than 3drinks/day/week 
More than or equal to 3drinks/day/week 
 
 
BMI  
Below 18.5 
18.5 – 24.9 
Above 25.0 
 
 
Level of Education 
Illiterate and school dropout 
School completed 
Graduate and above 
 
 
Marital Status 
Single 
Married 
Others 
Depression 
Most of the time 
Some of the time 
None of the time 
 
 
42 (46.15) 
49 (53.85) 
 
 
37 (45.68)                                           
26 (32.10)                                        
18 (22.23) 
 
 
 
31 (34.07)                                            
35 (38.46)                                         
25 (27.47)                                                                                                                
 
 
 
44 (48.35)                                         
21 (23.08)                                         
26 (28.57)                     
 
 
45 (49.45) 
34 (37.36) 
12 (13.19) 
 
 
15 (16.48) 
23 (25.27) 
53 (58.24) 
 
 
39 (42.86) 
21(23.08) 
31(34.07) 
 
 
 
 
 
 
28 (30.77) 
59 (64.84) 
04 (0.66) 
 
11 (12.09) 
31 (34.07) 
49 (53.85) 
  
 
 
 
137 (22.50) 
472 (77.50) 
 
 
304 (59.03) 
101 (19.61) 
110 (21.36) 
 
 
 
243 (39.90)  
245 (40.23) 
121 (19.87)
 
 
 
407 (66.83) 
113 (18.56) 
89 (14.61) 
 
 
355 (58.29) 
211 (34.65) 
43 (7.06) 
 
 
89 (14.61) 
458 (75.21) 
62 (10.18) 
 
 
279 (45.81) 
119 (19.54) 
211 (34.65) 
 
 
 
 
 
 
209 (34.32) 
391 (64.20) 
09 (1.48) 
 
43 (7.06) 
122 (20.03) 
444 (72.91) 
 
 
 
χ2  = 23.282,  
df=1, P<0.001 
 
 
χ2 = 7.326, 
df=2, P=0.026     
 
 
χ2 = 2.945,  
df=2, P=0.229                                                                 
 
 
 
χ2 = 14.430, 
df=2, P=0.001      
 
 
χ2 = 5.031, 
df=1, P=0.081     
 
 
χ2 = 140.224,  
df=2, P<0.001 
 
 
 
χ2=0.655, 
df=2,  P=0.721 
 
 
 
χ2  = 3.929,  
df=2, P=0.140 
 
 
 
χ2  = 13.811,  
df=2,  P=0.001 
 
 
Dass and Khandelwal / Indian J. Pharm. Biol. Res., 2017; 5(2):18-23 
 
Research Article  22 
 
[Table 1], [Table 2] and [Table 3] shows the results regarding 
the frequency of using analgesics and the commonly misused 
analgesics. Almost 44.7% of participants were seen to use 
analgesics over their lifetime, among them 13% were seen to 
misuse analgesics. Among the analgesics misused, 
paracetamol (53.8%), ibuprofen (30.8%), aspirin (8.8%) and 
diclofenac (6.6%) were the commonest. Almost 36.3% of 
participants misuse more than one analgesic in the past 30 
days.[Table 4] show the predictors of analgesic misuse. 
Statistically significant results were obtained for pain the past 
30 days (χ2  = 23.282, df=1, P<0.001), source of income (χ2 = 
7.326, df=2, P=0.026), smoking in the past 30 days (χ2 = 
14.430, df=2, P=0.001), body mass index (χ2 = 140.224, df=2, 
P<0.001) and depression (χ2  = 13.811, df=2, P=0.001).  
Discussion 
The study is an effort to understand the misuse of analgesics 
and predictors of analgesic misuse among the young adult 
population. [Table 1] shows the analgesics misused among the 
urban young adults of East Sikkim. In our study, almost 
around 13% of the participants were seen to misuse 
analgesics. For such users, the risk of getting addicted is the 
highest, especially when medicines are not taken under 
a physician’s supervision. [Table 2] and [Table 3] shows the 
analgesic use in the past 30 days and the commonly misused 
analgesics. In a research conducted among 295 clients of 
French pharmacies,
 
it has been stated that the problem of 
misusing OTC pain relievers may concern 6.8–17% of users. 
The risk of abuse was higher in the case of paracetamol users. 
[14] In another study conducted among adults of Wroclaw, 
Poland, the “heavy users” more regularly bought medicines 
with ibuprofen – 57%. [15] This was in compliance with the 
results reported in our study where paracetamol misused by 
almost 53.8% of the participants, which shows the highest and 
the next in line was ibuprofen (30.8%). [Table 2] from the 
Finnish study among participants 15-74 years, frequent 
analgesic use was related especially to daily or continuous 
pain and high pain intensity. Low mood, depression and not 
being employed also increased the probability for daily 
analgesic use. [16]
 
However, the Wroclaw, Poland study 
reported that the better-educated, professionally active people 
expect fast and optimal benefits and had no opportunities to 
visit their doctors quickly in case of pain. Buying and using 
analgesics without medical supervision was the best way to 
relieve pain. [15]
 
In this study, pain in the past 30 days 
(46.15%) and salaried individuals (45.68%) predicted 
analgesic misuse. From a study conducted in Denmark, 
measures of QoL, e.g., poor self-rated health & fitness and 
increasing age and smoking predicted analgesic use. Other 
predictors of analgesic use were nulliparity, low level of 
education, overweight/obesity & binge drinking.
 
Other 
predictors of analgesic use were underweight and 
marital/cohabiting status.
 
[17] Smoking in the past 30 days 
with less than 10 times (23.08%) and more than 10 times 
(28.57%) also predicted analgesic misuse in this study. 
Individuals with higher BMI (58.24%) caused an increased 
misuse of analgesics. Also depressed (46.15%) individuals 
were seen to misuse the analgesics.  
Conclusion 
Regular monthly analgesic use greater than or equal to 10 
doses was generally prevalent. Regular analgesic use was 
reported to be without medical advice and for pain other than 
everyday kind. Several socio-demographic and lifestyle 
factors along with smoking in the past one month were 
associated with a continuous regular analgesic misuse.  
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